C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
A03BB01 - butylscopolamine : Belongs to the class of belladonna alkaloids, semisynthetic, quaternary ammonium compounds. Used in the treatment of functional gastrointestinal disorders.
A03BB01 - butylscopolamine : Belongs to the class of belladonna alkaloids, semisynthetic, quaternary ammonium compounds. Used in the treatment of functional gastrointestinal disorders.
G04CA52 - tamsulosin and dutasteride : Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.
A02BC05 - esomeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC05 - esomeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
L01CB01 - etoposide : Belongs to the class of plant alkaloids and other natural products, podophyllotoxin derivatives. Used in the treatment of cancer.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
J05AF07 - tenofovir disoproxil : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AB11 - valaciclovir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
L01CA02 - vincristine : Belongs to the class of plant alkaloids and other natural products, vinca alkaloids and analogues. Used in the treatment of cancer.
R03CC02 - salbutamol : Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
J05AB01 - aciclovir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AB01 - aciclovir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C08CA01 - amlodipine : Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
C09DB01 - valsartan and amlodipine : Belongs to the class of angiotensin II receptor blockers (ARBs) and calcium channel blockers. Used in the treatment of cardiovascular disease.
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA02 - levodopa and decarboxylase inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
A03BB01 - butylscopolamine : Belongs to the class of belladonna alkaloids, semisynthetic, quaternary ammonium compounds. Used in the treatment of functional gastrointestinal disorders.
A03BB01 - butylscopolamine : Belongs to the class of belladonna alkaloids, semisynthetic, quaternary ammonium compounds. Used in the treatment of functional gastrointestinal disorders.
G04CA52 - tamsulosin and dutasteride : Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy.
A02BC05 - esomeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC05 - esomeprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
L01CB01 - etoposide : Belongs to the class of plant alkaloids and other natural products, podophyllotoxin derivatives. Used in the treatment of cancer.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
N04BA03 - levodopa, decarboxylase inhibitor and COMT inhibitor : Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
A02BC02 - pantoprazole : Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).
J05AF07 - tenofovir disoproxil : Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AB11 - valaciclovir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
L01CA02 - vincristine : Belongs to the class of plant alkaloids and other natural products, vinca alkaloids and analogues. Used in the treatment of cancer.
R03CC02 - salbutamol : Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
J05AB01 - aciclovir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
J05AB01 - aciclovir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.